Dox-induced expression of YAP-5SA dramatically reduced tumor growth while expression of YAP-5SAS94A had no effect (Fig. 2g), suggesting that YAP activation suppresses ER+ breast cancer growth in vivo and does so through binding to TEAD. Here, YAP1 is linked to breast carcinoma.